{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T08:12:51Z","timestamp":1790496771157,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.mayocp.2021.11.022","type":"journal-article","created":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T04:25:15Z","timestamp":1649478315000},"page":"931-940","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["C-Reactive Protein to Albumin Ratio in Patients Undergoing Transcatheter Aortic Valve Replacement"],"prefix":"10.1016","volume":"97","author":[{"given":"Hatim","family":"Seoudy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin","family":"Shamekhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Voigtl\u00e4nder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanne","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Kujat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bramlage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baravan","family":"Al-Kassou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf Yusuf","family":"Rangrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Schofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Puehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Lutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz","family":"Seiffert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Nickenig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenard","family":"Conradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Westermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Malte","family":"Sinning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derk","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.mayocp.2021.11.022_bib1","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jamda.2013.03.022","article-title":"Frailty consensus: a call to action","volume":"14","author":"Morley","year":"2013","journal-title":"J\u00a0Am Med Dir Assoc"},{"issue":"17","key":"10.1016\/j.mayocp.2021.11.022_bib2","article-title":"Clinical implications of physical function and resilience in patients undergoing transcatheter aortic valve replacement","volume":"9","author":"Goel","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.mayocp.2021.11.022_bib3","first-page":"123","article-title":"The relationship between preoperative frailty and outcomes following transcatheter aortic valve implantation: a systematic review and meta-analysis","volume":"3","author":"Anand","year":"2017","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"2","key":"10.1016\/j.mayocp.2021.11.022_bib4","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.amjcard.2015.03.061","article-title":"Relation of frailty to outcomes after transcatheter aortic valve replacement (from the PARTNER trial)","volume":"116","author":"Green","year":"2015","journal-title":"Am J Cardiol"},{"issue":"8","key":"10.1016\/j.mayocp.2021.11.022_bib5","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1253\/circj.CJ-17-0816","article-title":"Impact of frailty markers for unplanned hospital readmission following transcatheter aortic valve implantation","volume":"82","author":"Saji","year":"2018","journal-title":"Circ J"},{"issue":"28","key":"10.1016\/j.mayocp.2021.11.022_bib6","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1093\/eurheartj\/ehv756","article-title":"TAVI or No TAVI: identifying patients unlikely to benefit from transcatheter aortic valve implantation","volume":"37","author":"Puri","year":"2016","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.mayocp.2021.11.022_bib7","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jacc.2017.06.024","article-title":"Frailty in older adults undergoing aortic valve replacement: the FRAILTY-AVR Study","volume":"70","author":"Afilalo","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.mayocp.2021.11.022_bib8","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1016\/j.jtcvs.2014.07.087","article-title":"The impact of frailty on outcomes after cardiac surgery: a systematic review","volume":"148","author":"Sepehri","year":"2014","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"9","key":"10.1016\/j.mayocp.2021.11.022_bib9","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.jcin.2020.01.238","article-title":"Frailty and bleeding in older adults undergoing TAVR or SAVR: insights from the FRAILTY-AVR Study","volume":"13","author":"Bendayan","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.mayocp.2021.11.022_bib10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jcin.2019.08.015","article-title":"The effect and relationship of frailty indices on survival after transcatheter aortic valve replacement","volume":"13","author":"Kiani","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.mayocp.2021.11.022_bib11","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1016\/j.jtcvs.2014.10.013","article-title":"Frailty: it's hard to define, but you know it when you see it","volume":"148","author":"Allen","year":"2014","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"36","key":"10.1016\/j.mayocp.2021.11.022_bib12","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","article-title":"2017 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"38","author":"Baumgartner","year":"2017","journal-title":"Eur Heart J"},{"issue":"13","key":"10.1016\/j.mayocp.2021.11.022_bib13","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.4244\/EIJV13I13A241","article-title":"The business of risk","volume":"13","author":"Lennon","year":"2018","journal-title":"EuroIntervention"},{"issue":"13","key":"10.1016\/j.mayocp.2021.11.022_bib14","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.4244\/EIJ-D-17-00421","article-title":"TAVI risk scoring using established versus new scoring systems: role of the new STS\/ACC model","volume":"13","author":"Arsalan","year":"2018","journal-title":"EuroIntervention"},{"issue":"4","key":"10.1016\/j.mayocp.2021.11.022_bib15","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jcin.2017.11.012","article-title":"Improvement of risk prediction after transcatheter aortic valve replacement by combining frailty with conventional risk scores","volume":"11","author":"Schoenenberger","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"issue":"5","key":"10.1016\/j.mayocp.2021.11.022_bib16","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1093\/ejcts\/ezs533","article-title":"Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2)","volume":"42","author":"Kappetein","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"issue":"2","key":"10.1016\/j.mayocp.2021.11.022_bib17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/ehjqcco\/qcy044","article-title":"A\u00a0novel geriatric assessment frailty score predicts 2-year mortality after transcatheter aortic valve implantation","volume":"5","author":"Skaar","year":"2019","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"6","key":"10.1016\/j.mayocp.2021.11.022_bib18","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1080\/AC.68.6.8000007","article-title":"Impact of frailty scores on outcome of octogenarian patients undergoing transcatheter aortic valve implantation","volume":"68","author":"Kamga","year":"2013","journal-title":"Acta Cardiol"},{"issue":"6","key":"10.1016\/j.mayocp.2021.11.022_bib19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.14740\/jocmr2959w","article-title":"C-reactive protein and frailty in the elderly: a literature review","volume":"9","author":"Velissaris","year":"2017","journal-title":"J\u00a0Clin Med Res"},{"issue":"8","key":"10.1016\/j.mayocp.2021.11.022_bib20","doi-asserted-by":"crossref","first-page":"e1057","DOI":"10.4244\/EIJY15M10_09","article-title":"Albumin correlates with all-cause mortality in elderly patients undergoing transcatheter aortic valve implantation","volume":"12","author":"Bogdan","year":"2016","journal-title":"EuroIntervention"},{"issue":"3","key":"10.1016\/j.mayocp.2021.11.022_bib21","doi-asserted-by":"crossref","first-page":"299","DOI":"10.21470\/1678-9741-2019-0114","article-title":"The prognostic value of c-reactive protein to albumin ratio in patients with isolated degenerative aortic valve stenosis undergoing surgical aortic valve replacement","volume":"35","author":"Kahraman","year":"2020","journal-title":"Braz J Cardiovasc Surg"},{"issue":"3","key":"10.1016\/j.mayocp.2021.11.022_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059321","article-title":"C-reactive protein\/albumin ratio predicts 90-day mortality of septic patients","volume":"8","author":"Ranzani","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.mayocp.2021.11.022_bib23","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1007\/s00595-016-1448-8","article-title":"Ratio of C-reactive protein to albumin is a prognostic factor for operable non-small-cell lung cancer in elderly patients","volume":"47","author":"Miyazaki","year":"2017","journal-title":"Surg Today"},{"issue":"1","key":"10.1016\/j.mayocp.2021.11.022_bib24","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12872-018-0778-4","article-title":"Is there a C-reactive protein value beyond which one should consider infection as the cause of acute heart failure?","volume":"18","author":"Pereira","year":"2018","journal-title":"BMC Cardiovasc Disord"},{"issue":"6","key":"10.1016\/j.mayocp.2021.11.022_bib25","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s40520-015-0507-0","article-title":"Physical frailty in older people with severe aortic stenosis","volume":"28","author":"Fukui","year":"2016","journal-title":"Aging Clin Exp Res"},{"issue":"5","key":"10.1016\/j.mayocp.2021.11.022_bib26","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jcin.2012.02.012","article-title":"Evaluation of multidimensional geriatric assessment as a predictor of mortality and cardiovascular events after transcatheter aortic valve implantation","volume":"5","author":"Stortecky","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"issue":"7","key":"10.1016\/j.mayocp.2021.11.022_bib27","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.amjcard.2017.12.035","article-title":"Clinical frailty as an outcome predictor after transcatheter aortic valve implantation","volume":"121","author":"Rogers","year":"2018","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.mayocp.2021.11.022_bib28","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.amjcard.2016.11.019","article-title":"Prognostic value of hypoalbuminemia after transcatheter aortic valve implantation (from the Japanese Multicenter OCEAN-TAVI Registry)","volume":"119","author":"Yamamoto","year":"2017","journal-title":"Am J Cardiol"},{"issue":"9","key":"10.1016\/j.mayocp.2021.11.022_bib29","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.amjcard.2015.02.009","article-title":"Impact of pre-procedural serum albumin levels on outcome of patients undergoing transcatheter aortic valve replacement","volume":"115","author":"Koifman","year":"2015","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.mayocp.2021.11.022_bib30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.31083\/j.rcm.2019.03.524","article-title":"Serum albumin in patients undergoing transcatheter aortic valve replacement: a meta-analysis","volume":"20","author":"Hsieh","year":"2019","journal-title":"Rev Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.mayocp.2021.11.022_bib31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1536\/ihj.19-395","article-title":"Meta-analysis of the impact of pre-procedural serum albumin on mortality in patients undergoing transcatheter aortic valve replacement","volume":"61","author":"Liu","year":"2020","journal-title":"Int Heart J"},{"issue":"5","key":"10.1016\/j.mayocp.2021.11.022_bib32","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.athoracsur.2018.06.024","article-title":"Albumin is predictive of 1-year mortality after transcatheter aortic valve replacement","volume":"106","author":"Hebeler","year":"2018","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"10.1016\/j.mayocp.2021.11.022_bib33","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.athoracsur.2017.05.067","article-title":"Assessment of commonly used frailty markers for high- and extreme-risk patients undergoing transcatheter aortic valve replacement","volume":"104","author":"Forcillo","year":"2017","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"10.1016\/j.mayocp.2021.11.022_bib34","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jacc.2016.04.057","article-title":"Predicting early and late mortality after transcatheter aortic valve replacement","volume":"68","author":"Hermiller","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.mayocp.2021.11.022_bib35","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1111\/jgs.15070","article-title":"Addition of albumin to traditional risk score improved prediction of mortality in individuals undergoing transcatheter aortic valve replacement","volume":"65","author":"Grossman","year":"2017","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"4","key":"10.1016\/j.mayocp.2021.11.022_bib36","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0735-1097(01)01484-X","article-title":"C-reactive protein is increased in patients with degenerative aortic valvular stenosis","volume":"38","author":"Galante","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.mayocp.2021.11.022_bib37","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ahj.2008.04.011","article-title":"C-reactive protein predicts severity, progression, and prognosis of asymptomatic aortic valve stenosis","volume":"156","author":"Imai","year":"2008","journal-title":"Am Heart J"},{"issue":"5","key":"10.1016\/j.mayocp.2021.11.022_bib38","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/jocs.14499","article-title":"Prognostic impact of baseline C-reactive protein levels on mortality after transcatheter aortic valve implantation","volume":"35","author":"Takagi","year":"2020","journal-title":"J\u00a0Card Surg"},{"issue":"12","key":"10.1016\/j.mayocp.2021.11.022_bib39","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.118.007213","article-title":"Prognostic value of hs-CRP after transcatheter aortic valve implantation","volume":"11","author":"Iglesias-\u00c1lvarez","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.mayocp.2021.11.022_bib40","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.amjcard.2018.04.005","article-title":"Effect of serum C-reactive protein level on admission to predict mortality after transcatheter aortic valve implantation","volume":"122","author":"Hioki","year":"2018","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.mayocp.2021.11.022_bib41","doi-asserted-by":"crossref","first-page":"629","DOI":"10.4244\/EIJ-D-18-00059","article-title":"Combination of high-sensitivity C-reactive protein with logistic EuroSCORE improves risk stratification in patients undergoing TAVI","volume":"14","author":"Stundl","year":"2018","journal-title":"EuroIntervention"},{"issue":"5","key":"10.1016\/j.mayocp.2021.11.022_bib42","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.amjcard.2018.11.030","article-title":"Meta-analysis of impact of baseline N-terminalPro-brain natriuretic peptide levels on survival after transcatheter aortic valve implantation for aortic stenosis","volume":"123","author":"Takagi","year":"2019","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.mayocp.2021.11.022_bib43","first-page":"98","article-title":"All-Literature Investigation of Cardiovascular Evidence (ALICE) Group. Meta-analysis of impact of troponins on mortality after transcatheter aortic valve implantation","volume":"61","author":"Takagi","year":"2020","journal-title":"J\u00a0Cardiovasc Surg (Torino)"},{"issue":"12","key":"10.1016\/j.mayocp.2021.11.022_bib44","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1007\/s00380-019-01448-4","article-title":"Predictive value of preprocedural procalcitonin for short- and long-term mortality after transfemoral transcatheter aortic valve implantation","volume":"34","author":"Keranov","year":"2019","journal-title":"Heart Vessels"},{"issue":"8","key":"10.1016\/j.mayocp.2021.11.022_bib45","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1080\/1354750X.2018.1499127","article-title":"Multi-biomarker analysis in patients after transcatheter aortic valve implantation (TAVI)","volume":"23","author":"Mirna","year":"2018","journal-title":"Biomarkers"},{"key":"10.1016\/j.mayocp.2021.11.022_bib46","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ijcard.2019.11.101","article-title":"Prognostic implications of N-terminal pro-B-type natriuretic peptide in patients with normal left ventricular ejection fraction undergoing transcatheter aortic valve implantation","volume":"301","author":"Seoudy","year":"2020","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.mayocp.2021.11.022_bib47","article-title":"Periprocedural changes of NT-proBNP are associated with survival after transcatheter aortic valve implantation","volume":"8","author":"Seoudy","year":"2019","journal-title":"J\u00a0Am Heart Assoc"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619621008740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619621008740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T06:37:49Z","timestamp":1668580669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619621008740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0025619621008740"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2021.11.022","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"C-Reactive Protein to Albumin Ratio in Patients Undergoing Transcatheter Aortic Valve Replacement","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2021.11.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}